Beyond Air Secures Major GPO Deal, Expanding LungFit PH Access to 2,000 Hospitals
XAIR is trading near its 52-week low of $0.667 (11% above the low).
Summary
Beyond Air, Inc. announced a new national group purchasing agreement for its LungFit® PH system with a top-tier GPO, effective April 1, 2026. This significant partnership expands the company's commercial reach to nearly 2,000 additional U.S. hospitals and health systems, building on existing GPO relationships. For a micro-cap company that recently issued a 'going concern' warning in its Q3 2025 results, this agreement is a material positive development, directly addressing revenue generation and market penetration for its FDA-approved product. It provides a streamlined pathway for hospitals to adopt LungFit® PH, which offers a tankless, on-demand nitric oxide solution. Traders will closely watch the actual sales and revenue impact from this expanded access as the company works to improve its financial position.
At the time of this announcement, XAIR was trading at $0.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.3M. The 52-week trading range was $0.67 to $5.84. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.